Zimbabwe battles costly third-line ARVs treatment
|
ZIMBABWE is facing a significant financial strain as it is
allocating thousands of US dollars monthly to secure third-line Antiretrovirals
(ARVs) for ... |
ANAC Series Addresses HIV Risk and Barriers in Transgender Health Care
“ HIV testing as a whole in the United States will be severely—and I mean severely with all capital letters—cut, and the people that will suffer the ... View article...